EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Alantolactone as a Bioactive Sesquiterpene Lactone: Molecular Mechanisms and Anticancer Potential for Pharmaceutical Development

Alice Njolke Mafe, Lipana Dorcas Bappa, Javad Sharifi-Rad iD, William N Setzer iD, Daniela Calina iD

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70170 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Alice Njolke Mafe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Faculty of Sciences, Taraba State University, Jalingo, Taraba, Nigeria. Hauptthemen laut MEDLINE: Lactones, Sesquiterpenes, Eudesmane, Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 164 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a major global health challenge, responsible for millions of deaths each year. The limitations of current therapies, including adverse effects and drug resistance, have intensified the search for safer, more effective alternatives, particularly from natural sources. Alantolactone, a sesquiterpene lactone extracted from Inula helenium and related medicinal plants, has emerged as a promising anticancer candidate due to its diverse pharmacological actions. Although notable anticancer properties have been reported, its full therapeutic potential, mechanisms of action, and translational relevance remain insufficiently explored and scattered across the literature. This review provides a comprehensive synthesis of current evidence on alantolactone's anticancer effects. It examines its sources, phytochemical features, structure–activity relationships, bioavailability challenges, mechanistic pathways, and preclinical findings, alongside perspectives for future clinical application. Evidence shows that alantolactone modulates multiple molecular targets and signaling cascades, including NF‐κB, STAT3, MAPK, and apoptotic regulators. It demonstrates strong cytotoxic activity across diverse cancer cell lines and tumor‐bearing animal models. However, barriers such as low systemic bioavailability, limited pharmacokinetic profiling, and the absence of human clinical data impede its therapeutic development. Alantolactone nonetheless holds significant promise as a multi‐targeted anticancer compound with encouraging preclinical outcomes. Further research is required to address pharmacological limitations and establish safety and efficacy in clinical contexts. This review highlights alantolactone's potential contribution to future cancer therapy and emphasizes the need for interdisciplinary research to support its clinical translation and formulation advancement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactonesSesquiterpenes, EudesmaneNeoplasmsAntineoplastic Agents, PhytogenicAntineoplastic AgentsSesquiterpenesHumansAnimalsStructure-Activity RelationshipDrug DevelopmentInulaBiological Availability

Stichwörter der Autor:innen

alantolactoneanticancer agentsbioavailabilityphytochemicalspreclinical modelssesquiterpene lactonessignaling pathways

Substanzen

LactonesalantolactoneSesquiterpenes, EudesmaneAntineoplastic Agents, PhytogenicAntineoplastic AgentsSesquiterpenes

Autor:innen und Institutionen

  • Department of Biological Sciences, Faculty of Sciences, Taraba State University, Jalingo, Taraba, Nigeria.
  • Universidad Espíritu Santo, Samborondón, Ecuador.
  • Department of Medicine, College of Medicine, Korea University, Seoul, Republic of Korea.
  • Aromatic Plant Research Center, Lehi, Utah, USA.
  • Department of Chemistry, University of Alabama in Huntsville, Huntsville, Alabama, USA.
  • Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania.

ORCID-Profile: Javad Sharifi-Rad, William N Setzer, Daniela Calina

Zitieren

APA

Mafe, A. N., Bappa, L. D., Sharifi-Rad, J., Setzer, W. N., & Calina, D. (2025). Alantolactone as a Bioactive Sesquiterpene Lactone: Molecular Mechanisms and Anticancer Potential for Pharmaceutical Development. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70170

Vancouver

Mafe AN, Bappa LD, Sharifi-Rad J, Setzer WN, Calina D. Alantolactone as a Bioactive Sesquiterpene Lactone: Molecular Mechanisms and Anticancer Potential for Pharmaceutical Development. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70170

BibTeX
@article{Mafe2025,
  author = {Mafe, Alice Njolke and Bappa, Lipana Dorcas and Sharifi-Rad, Javad and Setzer, William N and Calina, Daniela},
  title = {Alantolactone as a Bioactive Sesquiterpene Lactone: Molecular Mechanisms and Anticancer Potential for Pharmaceutical Development},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70170}
}
Kostenlos starten →